Division of Cardiovascular Diseases

The National Heart, Lung, and Blood Institute (NHLBI), one of 27 institutes and centers at the National Institutes of Health (NIH), leads a national program in the causes, diagnosis, treatment, and prevention of diseases of the heart, blood vessels, lungs, and blood; in sleep disorders; and in the uses of blood and blood resources. The Institute is responsible for research on three of the four leading causes of death in the United States—heart disease, stroke, and chronic obstructive pulmonary disease. Through research in its laboratories and through extramural funding of investigator- and institute-initiated research grants and contracts, it conducts and supports scientific research that includes basic investigations, clinical studies, epidemiological studies, clinical trials, technology development and transfer, and demonstration and education projects. The Institute also supports research training and career development awards.

PURPOSE OF THE DIVISION

The Division of Cardiovascular Diseases (DCVD) provides leadership for a national and international extramural program in cardiovascular diseases (CVD) that integrates basic science and clinical research, including translational research, networks, and multicenter clinical trials. It designs, conducts, supports, and oversees research on the causes and prevention and treatment of diseases and disorders such as atherothrombosis; coronary artery disease (CAD); myocardial infarction and ischemia; heart failure; arrhythmia; sudden cardiac death; adult and pediatric congenital heart disease; cardiovascular complications of diabetes and obesity; and hypertension. It also supports and oversees research in vascular medicine and biologyand valvular, cerebral, renal, peripheral, and other cardiovascular disorders .  The DCVD fosters biotechnological research in genomics, proteomics, nanotechnology, imaging, device development, cell- and tissue-based therapeutics, and gene therapy, and in their uses as they relate to CVD.  It also supports training and career development programs in cardiovascular research at all educational levels from high school students to academic faculty, including programs for individuals from diverse populations.

• Office of the Director, DCVD
• Advanced Technologies & Surgery Branch
• Atherothrombosis & Coronary Artery Disease Branch
• Heart Development & Structural Diseases Branch
• Heart Failure & Arrhythmias Branch
• Vascular Biology & Hypertension Branch
• Office of Research Training & Career Development

DCVD STRATEGIC PLAN

The DCVD Strategic Plan was developed to implement strategies outlined in the NHLBI Strategic Plan. DCVD staff defined a series of goals, related to specific clinical problems, disease states, enabling technologies, research methodologies, and training needs. The plan includes 35 goals for research and training accomplishments, that will be used to guide the Division over the next 5 years. These goals were derived principally from the Level One Final Report recommendations germane to the DCVD mission as well as from other workshops and working groups participated in by the scientific and clinical community. The DCVD Strategic Plan is a "living document" and as such will be regularly reviewed and revised to reflect changing needs and directions.

• Executive Summary
• Goals
  • Enabling Technologies and Methodologies for Cardiovascular Diseases
  • Cardiovascular Clinical Problems or Disease States
  • Cardiovascular Research Training and Career Development

CONTACT INFORMATION

Division of Cardiovascular Diseases
National Heart, Lung, and Blood Institute
Two Rockledge Center - Suite 9160
6701 Rockledge Dr. - MSC 7940
Bethesda, MD 20892-7940

Additional phone numbers are available in the Abbreviated Staff Directory.